SBC Medical Enters U.S. Aesthetics Market With OrangeTwist

SBC Medical Group Holdings ( (SBC) ) has issued an announcement.

On January 5, 2026, SBC Medical Group Holdings completed a strategic minority equity investment in U.S.-based MedSpa chain OrangeTwist and entered into a structured collaboration framework with OrangeTwist and its institutional shareholders, Hildred Capital and Athyrium Capital, marking SBC Medical’s formal entry into the U.S. medical aesthetics market. The deal initiates Phase 1 of SBC Medical’s three-stage global expansion roadmap, centered on building a leading position in U.S. and international aesthetics and wellness through partnerships with high-performing regional operators, cross-border operational and clinical synergies between the U.S. and Asia, and a disciplined, multi-year plan to scale via acquisitions and joint ventures, underpinning its strategy to diversify revenues and strengthen its competitive positioning in high-growth health and wellness categories.

The most recent analyst rating on (SBC) stock is a Buy with a $5.00 price target. To see the full list of analyst forecasts on SBC Medical Group Holdings stock, see the SBC Stock Forecast page.

Spark’s Take on SBC Stock

According to Spark, TipRanks’ AI Analyst, SBC is a Outperform.

The score is driven primarily by strong profitability and a low-leverage balance sheet, tempered by declining TTM revenue growth and negative operating cash flow. Technicals are supportive with price above major moving averages and positive MACD, while valuation looks reasonable at a ~10.4 P/E. Corporate actions (buyback authorization and strategic acquisition) add incremental support but come with potential dilution considerations from the shelf registration.

To see Spark’s full report on SBC stock, click here.

More about SBC Medical Group Holdings

SBC Medical Group Holdings Incorporated is a comprehensive medical group that provides consulting and management services to a broad network of affiliated clinics across multiple medical fields, including advanced aesthetic medicine, dermatology, orthopedics, fertility treatment, dentistry, hair restoration, and ophthalmology. Supporting 258 clinics and more than six million patient visits annually, the Nasdaq-listed company operates through diverse clinic brands and is increasingly focused on global expansion in the United States and Asia, targeting high-growth health and wellness segments such as aesthetic and regenerative medicine and wellness solutions.

Average Trading Volume: 57,335

Technical Sentiment Signal: Sell

Current Market Cap: $444.2M

Find detailed analytics on SBC stock on TipRanks’ Stock Analysis page.